Studies on the effect of antidiabetic drugs on collagen in rats

Pakistan Journal of Biological Sciences

Volumn 16, Issue 22, 2013, Pages 1545-1550

  Lekshmi, U M D ^a   Reddy, P N ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

Antidiabetic drugs; Collagen; Hydroxyproline; Skin; Urinary excretion

Indexed keywords

ANTIDIABETIC AGENT; COLLAGEN; HYDROXYPROLINE;

ANIMAL; ARTICLE; DRUG EFFECT; FEMALE; HEART MUSCLE; KIDNEY; LIVER; METABOLISM; RAT; SKIN; TIME; URINE; WISTAR RAT;

ANIMALS; COLLAGEN; FEMALE; HYDROXYPROLINE; HYPOGLYCEMIC AGENTS; KIDNEY; LIVER; MYOCARDIUM; RATS; RATS, WISTAR; SKIN; TIME FACTORS;

EID: 84877357733     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2013.1545.1550     Document Type: Article

References (22)

1. Abrass, C.K., C.V. Peterson and G.J. Raugi, 1988. Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats. Diabetes, 37: 1695-1702.
2. Benoit, F.L., G.B. Theil and R.H. Watten, 1963. Hydroxyproline excretion in endocrine disease. Metabolism, 12: 1072-1082.
3. Bonadonna, G., M. Sonenberg and M.J. Merlino, 1965. Total urinary hydroxyproline excretion in diabetics before and after hypophysectomy and after growth hormone in adult hypopituitarism. Metabolism, 14: 832-835.
4. Engesaeter, L.B. and A.G. Skar, 1978. Effects of oxytetracycline on the mechanical properties of bone and skin in young rats. Acta Orthop., 49: 529-534.
5. Gerstein, H.C., 1998. Dysglycaemia: A cardiovascular risk factor. Diabetes Res. Clin. Pract, 40: S9-S14.
6. Haller, H., 1997. Postprandial glucose and vascular disease. Diabetic Med., 14: S50-S56.
7. Hamlin, C.R., R.R. Kohnand, J.H. Luschin, 1975. Apparent accelerated aging of human collagen in diabetes melhtus. Diabetes, 24: 902-904.
8. Hanefeld, M., T. Temelkova-Kurktschiev, F. Schaper, E. Henkel, G. Siegertand, C. Koehler, 2001. Impaired fasting glucose is not a risk factor for atherosclerosis. Diabetic Med., 16: 212-218.
9. Julio, R, D.R. Hassman, R.D. Madder, S.A. Brazinsky, J. Farrell, N. Khutoryansky and P.M. Hale, 2004. Repaglinide versus nateglinide monotherapy. A randomized, multicenter study. Diabetes Care, 27: 1265-1270.
10. Kivirikko, K.I., 1970. Urinary Excretion of Hydroxyproline in Health and Disease. In: International Review of Connective Tissue Research, Hall, D.A. and K. Jackson (Ed.). Academic Press, New York, pp: 93.
11. Lefebvre, P.J. and A.J. Scheen, 1998. The postprandial state and risk of cardiovascular disease. Diabetic Med., 15: S63-S68.
12. Levene, C.I. and J. Gross, 1959. Alterations in state of molecular aggregation of collagen induced in chick embryos by [3-aminopropionitrile (lathyrus factor). J. Exp. Med., 110: 771-790.
13. Mani, I. and U.V. Mani, 1986. Urinary excretion of hydroxyproline in diabetics under different modes of treatment. Indian J. Biochem. Biophys., 23: 297-298.
14. Neuman, RE. and M.A. Logan, 1950. The determination of hydroxyproline. J. Biol. Chem., 184: 299-306.
15. Okazaki, R, K. Matsuoka, A. Horiuchi, K. Maruyama and I. Okazaki, 1988. Assays of serum laminin and type III procollagen peptide for monitoring the clinical course of diabetic microangiopathy. Diabetes Res. Clin. Pract, 5: 163-170.
16. Paes, A.H., A. Bakker and C.J. Soe-Agnie, 1997. Impact of dosage frequency on patient compliance. Diabetes Care, 20: 1512-1517.
17. Perejda, A.J., 1987. Vascular and Cutaneous Complications of Diabetes Mellitus: The Role of Non-Enzymatic Glucosydation of Collagen. In: Connective Tissue Disease and Molecular Pathology of the Extracellular Matrix, Uitto, J. and A.J. Perejda (Ed.). Dekker, New York, pp: 475-490.
18. Prockop, D.J. and K.I. Kivirikko, 1967. Relationship of hydroxyproline excretion in urine to collagen metabolism. Ann. Internal Med., 66: 1243-1250.
19. Raza, M., O.A. Al-Shabanah, T.M. El-Hadiyah and A.A. Al-Majed, 2002. Effect of prolonged vigabatrin treatment of haematological and biochemical parameters in plasma, liver and kidney of Swiss albino mice. ScientiaPharmacuetica., 70: 135-145.
20. Sato, T., T. Saito, M. Kokubun, M. Ito, M. Inoue, K. Saito and K. Yoshinaga, 1980. Urinary excretion of O-hydroxylysylglycosides in diabetes mellitus. Tohoku J. Exp. Med., 131: 97-98.
21. Schnider, S.L. and R.R. Kohn, 1981. Effects of age and diabetics mellitus on the solubility and nonenzymatic glycosylation of human skin collagen. J. Clin. Inves., 67: 1630-1635.
22. Yue, D.K., S. McLennan, D.J. Handelsman, L. Delbridge, T. Reeve and J.R. Turtle, 1984. The effect of salicylates on nonenzymatic glycosylation and thermal stability of collagen in diabetic rats. Diabetes, 33: 745-751.